Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region.

OBJECTIVE To analyze the genotypes of the promoter region of the serotonin transporter gene (5-HTT) in patients with fibromyalgia (FM). METHODS Genomic DNA from 62 patients meeting the American College of Rheumatology 1990 criteria for FM and 110 healthy controls was analyzed by polymerase chain reaction. Additionally, the psychopathologic state of 52 of the FM patients was evaluated using the Beck Depression Inventory (BDI) and the Symptom Checklist-90-Revised (SCL-90-R). RESULTS The 5-HTTLPR genotypes in FM patients versus controls were distributed as follows: L/L 27% versus 34%, L/S 42% versus 50%, and S/S 31% versus 16%. FM patients with the S/S genotype had higher mean scores on the BDI and the SCL-90-R compared with those in the L/L and L/S groups. CONCLUSION A higher frequency of the S/S genotype of 5-HTT was found in FM patients compared with healthy controls. The S/S subgroup exhibited higher mean levels of depression and psychological distress. These results support the notion of altered serotonin metabolism in at least a subgroup of patients with FM.

[1]  F. Checler,et al.  Immunohistochemical Analysis of Cerebral Cortical and Vascular Lesions in the Primate Microcebus murinus Reveal Distinct Amyloid β1–42 and β1–40 Immunoreactivity Profiles , 2000, Neurobiology of Disease.

[2]  M. Schwarz,et al.  The T102C Polymorphism of the 5-HT2A-Receptor Gene in Fibromyalgia , 1999, Neurobiology of Disease.

[3]  M. Yunus,et al.  Genetic linkage analysis of multicase families with fibromyalgia syndrome. , 1999, The Journal of rheumatology.

[4]  E H Cook,et al.  Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. , 1998, Archives of general psychiatry.

[5]  Klaus-Peter Lesch,et al.  Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? , 1998, Biological Psychiatry.

[6]  Jeremy Veenstra-Vander Weele,et al.  Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder , 1998, Neuropsychopharmacology.

[7]  J. Olesen,et al.  Altered Allelic Distributions of the Serotonin Transporter Gene in Migraine Without Aura and Migraine with Aura , 1998, Cephalalgia.

[8]  M. Ackenheil,et al.  Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM , 1998, Zeitschrift für Rheumatologie.

[9]  C. Stockmeier Neurobiology of Serotonin in Depression and Suicide a , 1997, Annals of the New York Academy of Sciences.

[10]  A Benner,et al.  Serotonin transporter (5-HTT) gene variants associated with autism? , 1997, Human molecular genetics.

[11]  K. Lesch,et al.  Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. , 1997, Alcoholism, clinical and experimental research.

[12]  S. Kanba,et al.  Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. , 1997, American journal of medical genetics.

[13]  K. Lesch,et al.  Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene , 1997, Molecular Psychiatry.

[14]  D. Buskila,et al.  Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. , 1997, The Journal of rheumatology.

[15]  F. Wolfe,et al.  Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. , 1997, The Journal of rheumatology.

[16]  G. Kirov,et al.  Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease , 1997, Neuroreport.

[17]  A. Ravindran,et al.  Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder , 1997, Biological Psychiatry.

[18]  R. Carmi,et al.  Familial aggregation in the fihromyalgia syndrome , 1996 .

[19]  R. Murray,et al.  A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. , 1996, Molecular psychiatry.

[20]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[21]  C. Schmid,et al.  A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. , 1996, Arthritis and rheumatism.

[22]  R. Murray,et al.  The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. , 1996, Neuroreport.

[23]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[24]  J. Csernansky,et al.  Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. , 1996, Archives of general psychiatry.

[25]  R. Katz,et al.  Fibromyalgia, depression, and alcoholism: a family history study. , 1996, The Journal of rheumatology.

[26]  C. Fichtner,et al.  Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features. , 1995, Life sciences.

[27]  R. Salomon,et al.  Effects of sleep deprivation on serotonin function in depression , 1994, Biological Psychiatry.

[28]  M. Yunus Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. , 1994, Bailliere's clinical rheumatology.

[29]  R. Bennett,et al.  Assessing depression in fibromyalgia patients. , 1994, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[30]  Dc Washington Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[31]  T. Pap,et al.  [Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis]. , 1993, Medizinische Klinik.

[32]  J. Fawcett,et al.  Biochemical clues to a fibromyalgia-depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls. , 1992, The Journal of rheumatology.

[33]  Yunus Mb Towards a model of pathophysiology of fibromyalgia : aberrant central pain mechanisms with peripheral modulation , 1992 .

[34]  I. Russell,et al.  Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[35]  P. Keck,et al.  Comorbidity of fibromyalgia with medical and psychiatric disorders. , 1992, The American journal of medicine.

[36]  M. Yunus,et al.  Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. , 1992, The Journal of rheumatology.

[37]  I. Russell,et al.  Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. , 1992, The Journal of rheumatology.

[38]  N. Ahuja Affective spectrum disorder? , 1991, The American journal of psychiatry.

[39]  J. Parker,et al.  Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. , 2010 .

[40]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[41]  M. Ackenheil The mechanism of action of antidepressants revised. , 1990, Journal of neural transmission. Supplementum.

[42]  H. Pope,et al.  Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? , 1989, The Journal of rheumatology. Supplement.

[43]  S. Hathaway,et al.  MMPI-2 : Minnesota Multiphasic Personality Inventory-2 : manual for administration and scoring , 1989 .

[44]  R. W. Gracy,et al.  Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. , 1989, The Journal of rheumatology.

[45]  C. Robert Cloninger A systematic method for clinical description and classification of personality variants. A proposal. , 1987, Archives of general psychiatry.